Identification of molecular subtyping system and four-gene prognostic signature with immune-related genes for uveal melanoma. Issue 3 (February 2022)

• Record Type: Journal Article
• Authors: Xia, Fei; Yu, Zhilong; Deng, Aijun; Gao, Guohong
• Is Part Of: Experimental biology and medicine. Volume 247:Issue 3(2022)
• Page Start: 246
• Page End: 262
• Publication Date: 2022-02
• Subjects: : Uveal melanoma -- molecular subtyping system -- immune subtypes -- immune-related genes -- immune landscape -- prognostic signature -- immunotherapy -- bioinformatics; Physiology -- Periodicals; Biology, Experimental -- Periodicals; Medicine, Experimental -- Periodicals; 610.72
• DOI: 10.1177/15353702211053801
• Languages: English
• ISSNs: 1535-3702

Abstract

Immunotherapy is the most promising treatment for uveal melanoma patients with metastasis. Tumor microenvironment plays an essential role in tumor progression and greatly affects the efficacy of immunotherapy. This research constructed an immune-related subtyping system and discovered immune prognostic genes to further understand the immune mechanism in uveal melanoma. Immune-related genes were determined from literature. Gene expression profiles of uveal melanoma were clustered using consensus clustering based on immune-related genes. Subtypes were further divided by applying immune landscape, and weighted correlation network analysis was performed to construct immune gene modules. Univariate Cox regression analysis was conducted to generate a prognostic model. Enriched immune cells were determined after gene set enrichment analysis. Three major immune subtypes (IS1, IS2, and IS3) were identified, and IS2 could be further divided into IS2A and IS2B. The subtypes were closely associated with uveal melanoma prognosis. IS3 group had the most favorable prognosis and was sensitive to PD-1 inhibitor. Immune genes in IS1 group showed an overall higher expression than IS3 group. Six immune gene modules were identified, and the enrichment score of immune genes varied within immune subtypes. Four immune prognostic genes ( IL32, IRF1, SNX20, and VAV1 ) were found to be closely related to survival. This novel immune subtyping system and immune landscape provide a new understanding of immunotherapy in uveal melanoma. The four prognostic genes can predict prognosis of uveal melanoma patients and contribute to new development of targeted drugs.